The shakeout in the European diagnostics sector continues with the sale of diagnostics firm Munich Leukemia Laboratory (MLL) in the hands of Goldman Sachs. Co-founded by Claudia Haferlach and Torsten Haferlach in 2005, MLL is a diagnostics and research institution which is looking for a cure for leukaemia and lymphoma. MLL uses molecular and IT-supported…
©2021 All rights reserved LaingBuisson 
 in the hands of Goldman Sachs.){kind=link}